Latest News

Latest News

 

 

 

Carrier Advisory Committee Seeks Physician Expertise on Draft Local Coverage Determinations

Posted 7/19/18 (Thu)

 

Noridian maintains a Carrier Advisory Committee (CAC) in each state to serve as a formal mechanism for physicians to be informed of and participate in the development of a Local Coverage Determination (LCD) in an advisory capacity.
 
The Montana/North Dakota/Wyoming Carrier Advisory Committee, co-chaired by William Noyes, MD of Grand Forks, held a meeting in June and was attended by NDMA Executive Director Courtney Koebele.
 
As a result, CAC is seeking PHYSICIAN COMMENTS on the following LCDs NO LATER THAN AUGUST 14, 2018:
 
Click on the link to learn more; then forward your comments to Ms. Koebele at ckoebele@ndmed.com, OR contact via phone: 701-223-9475.
 
Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor

  • Focused ultrasound technique for treating tremors.
  • This was initially non-covered but there is literature supporting the service in certain well-define patients.
  • Literature does now support Benign Essential Tremors with certain criteria is met such as not eligible for surgery.
  • Not covered for Parkinson Disease.

MolDX: Decision DX-Melanoma

  • Defines the limited indications for limited people.

MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)

  • Defines limited coverage in limited circumstances.

MolDX: Pigmented Lesion Assay (PLA)

  • Evidence is insufficient to show any clinical utility so is a Noncoverage policy

 

Comments are greatly appreciated so any issues can be addressed before the policy finalizes.
                                               NDMA Executive Director Courtney Koebele.

 
Learn more.

 

Sorry no Tweets at this time

Follow Us!